Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice (Q38319272)

2 September 2017

title

Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice (English)

1 reference

2 September 2017

0 references

0 references

1 reference

1 reference

ChEBI release 2020-05-28

1 reference

Myoung Jin Son

1

1 reference

2 September 2017

Miki Minakawa

series ordinal

2

1 reference

2 September 2017

Yutaka Miura

series ordinal

3

1 reference

2 September 2017

Kazumi Yagasaki

series ordinal

4

1 reference

2 September 2017

publication date

13 December 2012

1 reference

European Journal of Nutrition

2 September 2017

published in

1 reference

2 September 2017

volume

52

1 reference

2 September 2017

issue

6

1 reference

2 September 2017

page(s)

1607-1619

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

The GLUT4 glucose transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Differential accumulation of advanced glycation end products in the course of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Advanced glycosylation end products in diabetic renal and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Polyphenols and health: current state and progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Antioxidant activity of the dihydrochalcones Aspalathin and Nothofagin and their corresponding flavones in relation to other Rooibos ( Aspalathus linearis ) Flavonoids, Epigallocatechin Gallate, and Trolox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

The antimutagenic activity of the major flavonoids of rooibos (Aspalathus linearis): some dose-response effects on mutagen activation-flavonoid interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Influence of processing stages on antimutagenic and antioxidant potentials of rooibos tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Chemoprotective properties of rooibos (Aspalathus linearis), honeybush (Cyclopia intermedia) herbal and green and black (Camellia sinensis) teas against cancer promotion induced by fumonisin B1 in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Selective bronchodilatory effect of Rooibos tea (Aspalathus linearis) and its flavonoid, chrysoeriol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Hypolipidemic action of the soybean isoflavones genistein and genistin in glomerulonephritic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Serum advanced glycation end products (AGEs) are associated with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Advanced glycation end products and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Transgenic expression of antioxidant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Comparison of the Antioxidant Activity of Aspalathin with That of Other Plant Phenols of Rooibos Tea (Aspalathus linearis), α-Tocopherol, BHT, and BHA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Bioavailability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Dose translation from animal to human studies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-012-0466-6

Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin

21 January 2018

1 reference

12 December 2020

Regulatory mechanism for the stimulatory action of genistein on glucose uptake in vitro and in vivo

1 reference

12 December 2020

Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells

1 reference

12 December 2020

Studies of anti-inflammatory effects of Rooibos tea in rats

1 reference

12 December 2020

Involvement of protein kinase C activation in L-leucine-induced stimulation of protein synthesis in l6 myotubes

1 reference

12 December 2020

Advanced glycation end products, their receptors and diabetic angiopathy

1 reference

12 December 2020

5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase

1 reference

12 December 2020

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

12 December 2020

Novel concepts in insulin regulation of hepatic gluconeogenesis

1 reference

12 December 2020

Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity

1 reference

12 December 2020

10.1007/S00394-012-0466-6

Identifiers

DOI

1 reference

2 September 2017

1 reference